世界の抗感染性眼炎販売市場2021

QYResearchが発行した調査報告書(QYR21JN7568)
◆英語タイトル:Global Anti-Infective Ophthalmic Sales Market Report 2021
◆商品コード:QYR21JN7568
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月16日(※2024年版があります。お問い合わせください。)
◆ページ数:135
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥888,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

QYリサーチ社の本調査レポートでは、世界の抗感染性眼炎市場について種類別(抗菌、抗ウイルス、抗真菌、抗寄生虫、その他)、用途別(病院、診療所、家庭用、その他)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2016年~2027年までの市場規模と予測(販売量、売上、価格)、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・抗感染性眼炎市場の概要
・世界の主要地域別抗感染性眼炎市場規模2016-2027
・主要プレイヤーの競争状況・市場シェア
・世界の抗感染性眼炎市場規模2016-2021:種類別(抗菌、抗ウイルス、抗真菌、抗寄生虫、その他)
・世界の抗感染性眼炎市場予測2012-2027:種類別(抗菌、抗ウイルス、抗真菌、抗寄生虫、その他)
・世界の抗感染性眼炎市場規模2016-2021:用途別(病院、診療所、家庭用、その他)
・世界の抗感染性眼炎市場予測2012-2027:用途別(病院、診療所、家庭用、その他)
・抗感染性眼炎のアメリカ市場規模と予測2016-2021
・抗感染性眼炎のヨーロッパ市場規模と予測2016-2021
・抗感染性眼炎の中国市場規模と予測2016-2021
・抗感染性眼炎の日本市場規模と予測2016-2021
・抗感染性眼炎の東南アジア市場規模と予測2016-2021
・抗感染性眼炎のインド市場規模と予測2016-2021
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Novartis、Allergan、Bausch Health、Santen Pharmaceutical、Lupin Pharmaceuticals、Apotex、Akorn)
・抗感染性眼炎の製造コスト分析
・販売チャネル、流通業者、顧客
・抗感染性眼炎の市場動向・機会・課題
・調査の結論
【レポートの概要】

Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.
In terms of region, the global ophthalmic anti-infective market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global ophthalmic anti-infective market due to availability of advanced drug formulations in the region. Awareness among people about diseases is also a major factor boosting the market in the region. The ophthalmic anti-infective market in Asia Pacific is anticipated to expand at a rapid pace due to increase in incidence of eye infection in the region. Lack of awareness about diseases and unavailability of advanced medication and formulations in underdeveloped countries, such as Lebanon, Syria, Cyprus, Turkey, and Iraq are likely to restrain the growth of the ophthalmic anti-infective market in Middle East & Africa.

Market Analysis and Insights: Global Anti-Infective Ophthalmic Market
The global Anti-Infective Ophthalmic market was valued at US$ 1468.1 in 2020 and will reach US$ 1558.4 million by the end of 2027, growing at a CAGR of 1.0% during 2022-2027.

Global Anti-Infective Ophthalmic Scope and Market Size
The global Anti-Infective Ophthalmic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Infective Ophthalmic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Antibacterial
Antiviral
Antifungal
Anti-Parasitic
Others

Segment by Application
Hospital
Clinic
Household
Others

The Anti-Infective Ophthalmic market is analysed and market size information is provided by regions (countries). Segment by Application, the Anti-Infective Ophthalmic market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Novartis
Allergan
Bausch Health
Santen Pharmaceutical
Lupin Pharmaceuticals
Apotex
Akorn

【レポートの目次】

1 Anti-Infective Ophthalmic Market Overview
1.1 Anti-Infective Ophthalmic Product Scope
1.2 Anti-Infective Ophthalmic Segment by Type
1.2.1 Global Anti-Infective Ophthalmic Sales by Type (2016 & 2021 & 2027)
1.2.2 Antibacterial
1.2.3 Antiviral
1.2.4 Antifungal
1.2.5 Anti-Parasitic
1.2.6 Others
1.3 Anti-Infective Ophthalmic Segment by Application
1.3.1 Global Anti-Infective Ophthalmic Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.3.5 Others
1.4 Anti-Infective Ophthalmic Market Estimates and Forecasts (2016-2027)
1.4.1 Global Anti-Infective Ophthalmic Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Anti-Infective Ophthalmic Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Anti-Infective Ophthalmic Price Trends (2016-2027)

2 Anti-Infective Ophthalmic Estimates and Forecasts by Region
2.1 Global Anti-Infective Ophthalmic Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Anti-Infective Ophthalmic Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Anti-Infective Ophthalmic Sales Market Share by Region (2016-2021)
2.2.2 Global Anti-Infective Ophthalmic Revenue Market Share by Region (2016-2021)
2.3 Global Anti-Infective Ophthalmic Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Anti-Infective Ophthalmic Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Anti-Infective Ophthalmic Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Anti-Infective Ophthalmic Estimates and Projections (2016-2027)
2.4.2 Europe Anti-Infective Ophthalmic Estimates and Projections (2016-2027)
2.4.3 China Anti-Infective Ophthalmic Estimates and Projections (2016-2027)
2.4.4 Japan Anti-Infective Ophthalmic Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Anti-Infective Ophthalmic Estimates and Projections (2016-2027)
2.4.6 India Anti-Infective Ophthalmic Estimates and Projections (2016-2027)
3 Global Anti-Infective Ophthalmic Competition Landscape by Players
3.1 Global Top Anti-Infective Ophthalmic Players by Sales (2016-2021)
3.2 Global Top Anti-Infective Ophthalmic Players by Revenue (2016-2021)
3.3 Global Anti-Infective Ophthalmic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Infective Ophthalmic as of 2020)
3.4 Global Anti-Infective Ophthalmic Average Price by Company (2016-2021)
3.5 Manufacturers Anti-Infective Ophthalmic Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Anti-Infective Ophthalmic Market Size by Type
4.1 Global Anti-Infective Ophthalmic Historic Market Review by Type (2016-2021)
4.1.1 Global Anti-Infective Ophthalmic Sales Market Share by Type (2016-2021)
4.1.2 Global Anti-Infective Ophthalmic Revenue Market Share by Type (2016-2021)
4.1.3 Global Anti-Infective Ophthalmic Price by Type (2016-2021)
4.2 Global Anti-Infective Ophthalmic Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Anti-Infective Ophthalmic Sales Forecast by Type (2022-2027)
4.2.2 Global Anti-Infective Ophthalmic Revenue Forecast by Type (2022-2027)
4.2.3 Global Anti-Infective Ophthalmic Price Forecast by Type (2022-2027)
5 Global Anti-Infective Ophthalmic Market Size by Application
5.1 Global Anti-Infective Ophthalmic Historic Market Review by Application (2016-2021)
5.1.1 Global Anti-Infective Ophthalmic Sales Market Share by Application (2016-2021)
5.1.2 Global Anti-Infective Ophthalmic Revenue Market Share by Application (2016-2021)
5.1.3 Global Anti-Infective Ophthalmic Price by Application (2016-2021)
5.2 Global Anti-Infective Ophthalmic Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Anti-Infective Ophthalmic Sales Forecast by Application (2022-2027)
5.2.2 Global Anti-Infective Ophthalmic Revenue Forecast by Application (2022-2027)
5.2.3 Global Anti-Infective Ophthalmic Price Forecast by Application (2022-2027)

6 North America Anti-Infective Ophthalmic Market Facts & Figures
6.1 North America Anti-Infective Ophthalmic Sales by Company
6.1.1 North America Anti-Infective Ophthalmic Sales by Company (2016-2021)
6.1.2 North America Anti-Infective Ophthalmic Revenue by Company (2016-2021)
6.2 North America Anti-Infective Ophthalmic Sales Breakdown by Type
6.2.1 North America Anti-Infective Ophthalmic Sales Breakdown by Type (2016-2021)
6.2.2 North America Anti-Infective Ophthalmic Sales Breakdown by Type (2022-2027)
6.3 North America Anti-Infective Ophthalmic Sales Breakdown by Application
6.3.1 North America Anti-Infective Ophthalmic Sales Breakdown by Application (2016-2021)
6.3.2 North America Anti-Infective Ophthalmic Sales Breakdown by Application (2022-2027)

7 Europe Anti-Infective Ophthalmic Market Facts & Figures
7.1 Europe Anti-Infective Ophthalmic Sales by Company
7.1.1 Europe Anti-Infective Ophthalmic Sales by Company (2016-2021)
7.1.2 Europe Anti-Infective Ophthalmic Revenue by Company (2016-2021)
7.2 Europe Anti-Infective Ophthalmic Sales Breakdown by Type
7.2.1 Europe Anti-Infective Ophthalmic Sales Breakdown by Type (2016-2021)
7.2.2 Europe Anti-Infective Ophthalmic Sales Breakdown by Type (2022-2027)
7.3 Europe Anti-Infective Ophthalmic Sales Breakdown by Application
7.3.1 Europe 135 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 135 Sales Breakdown by Application (2022-2027)

8 China Anti-Infective Ophthalmic Market Facts & Figures
8.1 China Anti-Infective Ophthalmic Sales by Company
8.1.1 China Anti-Infective Ophthalmic Sales by Company (2016-2021)
8.1.2 China Anti-Infective Ophthalmic Revenue by Company (2016-2021)
8.2 China Anti-Infective Ophthalmic Sales Breakdown by Type
8.2.1 China Anti-Infective Ophthalmic Sales Breakdown by Type (2016-2021)
8.2.2 China Anti-Infective Ophthalmic Sales Breakdown by Type (2022-2027)
8.3 China Anti-Infective Ophthalmic Sales Breakdown by Application
8.3.1 China 244 Sales Breakdown by Application (2016-2021)
8.3.2 China 244 Sales Breakdown by Application (2022-2027)

9 Japan Anti-Infective Ophthalmic Market Facts & Figures
9.1 Japan Anti-Infective Ophthalmic Sales by Company
9.1.1 Japan Anti-Infective Ophthalmic Sales by Company (2016-2021)
9.1.2 Japan Anti-Infective Ophthalmic Revenue by Company (2016-2021)
9.2 Japan Anti-Infective Ophthalmic Sales Breakdown by Type
9.2.1 Japan Anti-Infective Ophthalmic Sales Breakdown by Type (2016-2021)
9.2.2 Japan Anti-Infective Ophthalmic Sales Breakdown by Type (2022-2027)
9.3 Japan Anti-Infective Ophthalmic Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Anti-Infective Ophthalmic Market Facts & Figures
10.1 Southeast Asia Anti-Infective Ophthalmic Sales by Company
10.1.1 Southeast Asia Anti-Infective Ophthalmic Sales by Company (2016-2021)
10.1.2 Southeast Asia Anti-Infective Ophthalmic Revenue by Company (2016-2021)
10.2 Southeast Asia Anti-Infective Ophthalmic Sales Breakdown by Type
10.2.1 Southeast Asia Anti-Infective Ophthalmic Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Anti-Infective Ophthalmic Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Anti-Infective Ophthalmic Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Anti-Infective Ophthalmic Market Facts & Figures
11.1 India Anti-Infective Ophthalmic Sales by Company
11.1.1 India Anti-Infective Ophthalmic Sales by Company (2016-2021)
11.1.2 India Anti-Infective Ophthalmic Revenue by Company (2016-2021)
11.2 India Anti-Infective Ophthalmic Sales Breakdown by Type
11.2.1 India Anti-Infective Ophthalmic Sales Breakdown by Type (2016-2021)
11.2.2 India Anti-Infective Ophthalmic Sales Breakdown by Type (2022-2027)
11.3 India Anti-Infective Ophthalmic Sales Breakdown by Application
11.3.1 India Anti-Infective Ophthalmic Sales Breakdown by Application (2016-2021)
11.3.2 India Anti-Infective Ophthalmic Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Anti-Infective Ophthalmic Business
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Business Overview
12.1.3 Novartis Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novartis Anti-Infective Ophthalmic Products Offered
12.1.5 Novartis Recent Development
12.2 Allergan
12.2.1 Allergan Corporation Information
12.2.2 Allergan Business Overview
12.2.3 Allergan Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Allergan Anti-Infective Ophthalmic Products Offered
12.2.5 Allergan Recent Development
12.3 Bausch Health
12.3.1 Bausch Health Corporation Information
12.3.2 Bausch Health Business Overview
12.3.3 Bausch Health Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Bausch Health Anti-Infective Ophthalmic Products Offered
12.3.5 Bausch Health Recent Development
12.4 Santen Pharmaceutical
12.4.1 Santen Pharmaceutical Corporation Information
12.4.2 Santen Pharmaceutical Business Overview
12.4.3 Santen Pharmaceutical Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Santen Pharmaceutical Anti-Infective Ophthalmic Products Offered
12.4.5 Santen Pharmaceutical Recent Development
12.5 Lupin Pharmaceuticals
12.5.1 Lupin Pharmaceuticals Corporation Information
12.5.2 Lupin Pharmaceuticals Business Overview
12.5.3 Lupin Pharmaceuticals Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Lupin Pharmaceuticals Anti-Infective Ophthalmic Products Offered
12.5.5 Lupin Pharmaceuticals Recent Development
12.6 Apotex
12.6.1 Apotex Corporation Information
12.6.2 Apotex Business Overview
12.6.3 Apotex Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Apotex Anti-Infective Ophthalmic Products Offered
12.6.5 Apotex Recent Development
12.7 Akorn
12.7.1 Akorn Corporation Information
12.7.2 Akorn Business Overview
12.7.3 Akorn Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Akorn Anti-Infective Ophthalmic Products Offered
12.7.5 Akorn Recent Development

13 Anti-Infective Ophthalmic Manufacturing Cost Analysis
13.1 Anti-Infective Ophthalmic Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Anti-Infective Ophthalmic
13.4 Anti-Infective Ophthalmic Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Anti-Infective Ophthalmic Distributors List
14.3 Anti-Infective Ophthalmic Customers

15 Market Dynamics
15.1 Anti-Infective Ophthalmic Market Trends
15.2 Anti-Infective Ophthalmic Drivers
15.3 Anti-Infective Ophthalmic Market Challenges
15.4 Anti-Infective Ophthalmic Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の抗感染性眼炎販売市場2021(Global Anti-Infective Ophthalmic Sales Market Report 2021)]についてメールでお問い合わせはこちらでお願いします。